Sterling Knight Ipamorelin 1 vial (10 mg)

Ipamorelin

is a potent peptide that selectively activates the ghrelin/growth hormone secretagogue receptor, functioning as a growth hormone secretagogue. This pentapeptide, with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, is derived from GHRP-1.

Mécanisme d'action

Ipamorelin effectively binds to GHSR to induce a biological response. This receptor, located in the ventromedial nucleus of the hypothalamus (VMN), regulates energy homeostasis, influencing caloric intake and body weight regulation by signaling hunger.

Key Benefits

• Ipamorelin uniquely spares prolactin, a hormone vital for milk production and immune system regulation, ensuring no interference during its use.
• It has no reported effects on Follicle-Stimulating Hormone or Luteinizing Hormone, which are crucial for ovulation in women and testosterone production in men.
• No impact on Thyroid-Stimulating Hormone has been recorded, preserving metabolic regulation and preventing conditions like hyperthyroidism or hypothyroidism.
• Ipamorelin does not stimulate Adrenocorticotropic Hormone secretion, mitigating risks associated with stress-induced cortisol spikes that can impair immune function.
• No cortisol-related adverse effects are associated with this peptide, which maintains optimal blood sugar levels and aids in stress response.
• Cortisol regulation supports blood pressure coordination and overall immune system function.

Dosage recommandé

The typical Ipamorelin dosage ranges from 200 to 300 mcg, administered 2 to 3 times daily, with twelve-week cycles commonly preferred.

• Usage Frequency: 2-3 times daily.
• Injection Site: Subcutaneously in the abdominal area.
• Single Injection Dosage: 200-300 mcg.